Paul D.P. Pharoah

96.9k total citations · 6 hit papers
340 papers, 19.9k citations indexed

About

Paul D.P. Pharoah is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Paul D.P. Pharoah has authored 340 papers receiving a total of 19.9k indexed citations (citations by other indexed papers that have themselves been cited), including 147 papers in Genetics, 97 papers in Molecular Biology and 88 papers in Oncology. Recurrent topics in Paul D.P. Pharoah's work include BRCA gene mutations in cancer (108 papers), Genetic Associations and Epidemiology (47 papers) and Cancer Genomics and Diagnostics (44 papers). Paul D.P. Pharoah is often cited by papers focused on BRCA gene mutations in cancer (108 papers), Genetic Associations and Epidemiology (47 papers) and Cancer Genomics and Diagnostics (44 papers). Paul D.P. Pharoah collaborates with scholars based in United Kingdom, United States and Australia. Paul D.P. Pharoah's co-authors include Carlos Caldas, Douglas F. Easton, Alison M. Dunning, Bruce A.J. Ponder, Antonis C. Antoniou, Bruce A.J. Ponder, Nora Pashayan, Monica Hollstein, Catherine Whibley and Parry Guilford and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Paul D.P. Pharoah

329 papers receiving 19.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Polygenic susceptibility to breast cancer and implications for prevention

2002 590 citations Paul D.P. Pharoah, Antonis C. Antoniou et al. profile →
Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk

2015 579 citations Douglas F. Easton, Paul D.P. Pharoah et al. profile →
Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype

2009 562 citations Gillian C. Barnett, Catharine West et al. Nature reviews. Cancer profile →
p53 polymorphisms: cancer implications

2009 513 citations Paul D.P. Pharoah et al. Nature reviews. Cancer profile →
Patterns of Immune Infiltration in Breast Cancer and Their Clinical Implications: A Gene-Expression-Based Retrospective Study

2016 436 citations Paul D.P. Pharoah, Carlos Caldas et al. PLoS Medicine profile →
BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors

2019 386 citations Andrew Lee, Alex Cunningham et al. Genetics in Medicine profile →

Peers

Countries citing papers authored by Paul D.P. Pharoah

Since Specialization

Citations

This map shows the geographic impact of Paul D.P. Pharoah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul D.P. Pharoah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul D.P. Pharoah more than expected).

Fields of papers citing papers by Paul D.P. Pharoah

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul D.P. Pharoah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul D.P. Pharoah. The network helps show where Paul D.P. Pharoah may publish in the future.

Co-authorship network of co-authors of Paul D.P. Pharoah

This figure shows the co-authorship network connecting the top 25 collaborators of Paul D.P. Pharoah. A scholar is included among the top collaborators of Paul D.P. Pharoah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul D.P. Pharoah. Paul D.P. Pharoah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Estimation of age of onset and progression of breast cancer by absolute risk dependent on polygenic risk score and other risk factors 2024 ·Cancer ·(unknown), Ardo van den Hout, Antonis C. Antoniou, Mitul Shah, (unknown), (unknown), Douglas F. Easton, Paul D.P. Pharoah, Nora Pashayan	7
2	An updated PREDICT breast cancer prognostic model including the benefits and harms of radiotherapy 2024 ·npj Breast Cancer ·(unknown), Gordon Wishart, Paul D.P. Pharoah	6
3	Predicted Proteome Association Studies of Breast, Prostate, Ovarian, and Endometrial Cancers Implicate Plasma Protein Regulation in Cancer Susceptibility 2023 ·Cancer Epidemiology Biomarkers & Prevention ·(unknown), Paul D.P. Pharoah, Simon A. Gayther, Ani Manichaikul, Hae Kyung Im, Siddhartha Kar, Joellen M. Schildkraut, Heather E. Wheeler	4
4	Functional analysis of the 1p34.3 risk locus implicates GNL2 in high-grade serous ovarian cancer 2021 ·The American Journal of Human Genetics ·Koji Nakamura, Brett M. Reid, Ann Chen, Zhihua Chen, Ellen L. Goode, Jennifer B. Permuth, Jamie K. Teer, Jonathan P. Tyrer, Xiaoqing Yu, Peter A. Kanetsky, Paul D.P. Pharoah, Simon A. Gayther, Thomas A. Sellers, Kate Lawrenson, Florian A. Karreth	7
5	Breast cancer risk factors and their effects on survival: a Mendelian randomisation study 2020 ·BMC Medicine ·(unknown), Anna Morra, Sander Canisius, Jenny Chang‐Claude, Siddhartha Kar, Wei Zheng, Stig E. Bojesen, Doug Easton, Paul D.P. Pharoah, Marjanka K. Schmidt	57
6	Going to extremes: determinants of extraordinary response and survival in patients with cancer 2019 ·Nature reviews. Cancer ·(unknown), Alan Herschtal, Brad H. Nelson, Anna DeFazio, Ellen L. Goode, Susan J. Ramus, Ahwan Pandey, Jessica A. Beach, Sián Fereday, Andrew Berchuck, Stéphanie Lheureux, Celeste Leigh Pearce, Paul D.P. Pharoah, Malcolm C. Pike, Dale W. Garsed, David D.L. Bowtell	24
7	Individual prognosis at diagnosis in nonmetastatic prostate cancer: Development and external validation of the PREDICT Prostate multivariable model 2019 ·PLoS Medicine ·David Thurtle, David Greenberg, (unknown), Hong Hong Huang, Paul D.P. Pharoah, Vincent J. Gnanapragasam	41
8	Development and External Validation of Prediction Models for 10-Year Survival of Invasive Breast Cancer. Comparison with PREDICT and CancerMath 2018 ·Clinical Cancer Research ·(unknown), Paul D.P. Pharoah, Christopher Jackson, Paul J. Newcombe	11
9	Incorporating truncating variants in PALB2, CHEK2, and ATM into the BOADICEA breast cancer risk model 2016 ·Genetics in Medicine ·Andrew Lee, Alex Cunningham, Marc Tischkowitz, Jacques Simard, Paul D.P. Pharoah, Douglas F. Easton, Antonis C. Antoniou	58
10	Patients with a High Polygenic Risk of Breast Cancer do not have An Increased Risk of Radiotherapy Toxicity 2015 ·Clinical Cancer Research ·Leila Dorling, Gillian C. Barnett, Kyriaki Michailidou, Charlotte E. Coles, N.G. Burnet, John Yarnold, Rebecca Elliott, Alison M. Dunning, Paul D.P. Pharoah, Catharine West	15
11	Population Distribution of Lifetime Risk of Ovarian Cancer in the United States 2015 ·Cancer Epidemiology Biomarkers & Prevention ·Celeste Leigh Pearce, Daniel O. Stram, Roberta B. Ness, Douglas Stram, Lynda D. Roman, Claire Templeman, Alice W. Lee, Usha Menon, Peter A. Fasching, Jessica N. McAlpine, Jennifer A. Doherty, Francesmary Modugno, Joellen M. Schildkraut, Mary Anne Rossing, David G. Huntsman, Anna H. Wu, Andrew Berchuck, Malcolm C. Pike, Paul D.P. Pharoah	71
12	Do Health Professionals Need Additional Competencies for Stratified Cancer Prevention Based on Genetic Risk Profiling? 2015 ·Journal of Personalized Medicine ·Susmita Chowdhury, Lidewij Henneman, Tom Dent, Alison Hall, Alice R. Burton, Paul D.P. Pharoah, Nora Pashayan, Hilary Burton	13
13	Replication of Genetic Polymorphisms Reported to Be Associated with Taxane-Related Sensory Neuropathy in Patients with Early Breast Cancer Treated with Paclitaxel 2014 ·Clinical Cancer Research ·Jean Abraham, Qi Guo, Leila Dorling, Jonathan P. Tyrer, Susan Ingle, (unknown), Anne-Laure Vallier, Louise Hiller, Stephen R. Russell, Linda Jones, S. Bowden, Janet Dunn, Christopher Poole, Carlos Caldas, Paul D.P. Pharoah, Helena Earl	82
14	TGF-β Signaling Pathway and Breast Cancer Susceptibility 2011 ·Cancer Epidemiology Biomarkers & Prevention ·Serena Scollen, Craig Luccarini, Caroline Baynes, Kristy Driver, Manjeet K. Humphreys, Montserrat García‐Closas, Jonine D. Figueroa, Jolanta Lissowska, Paul D.P. Pharoah, Douglas F. Easton, Robin Hesketh, James C. Metcalfe, Alison M. Dunning	47
15	Public health implications of personalised screening for cancer: The First Collaborative Oncological Gene-environment Study (COGS) Workshop findings 2011 ·UCL Discovery (University College London) ·(unknown), Nora Pashayan, Andy Hall, Tom Dent, Georgios Lyratzopoulos, Paul D.P. Pharoah, H. Burton	2
16	A Kallikrein 15 (KLK15) single nucleotide polymorphism located close to a novel exon shows evidence of association with poor ovarian cancer survival 2011 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), (unknown), (unknown), Olivia L. Tan, (unknown), (unknown), (unknown), (unknown), (unknown), Susan J. Ramus, Simon A. Gayther, Paul D.P. Pharoah, Mary‐Anne Kedda, Amanda B. Spurdle, Judith A. Clements	13
17	Assessment of Automated Image Analysis of Breast Cancer Tissue Microarrays for Epidemiologic Studies 2010 ·Cancer Epidemiology Biomarkers & Prevention ·Kelly L. Bolton, Montserrat García‐Closas, Ruth M. Pfeiffer, Máire A. Duggan, William Howat, Stephen M. Hewitt, Xiaohong R. Yang, Robert Cornelison, Sarah L. Anzick, Paul S. Meltzer, Sean Davis, Petra H. Lenz, Jonine D. Figueroa, Paul D.P. Pharoah, Mark E. Sherman	48
18	Telomere Length in Prospective and Retrospective Cancer Case-Control Studies 2010 ·Cancer Research ·Karen A. Pooley, Manjinder S. Sandhu, Jonathan P. Tyrer, Mitul Shah, Kristy Driver, Robert Luben, Sheila Bingham, Bruce A.J. Ponder, Paul D.P. Pharoah, Kay‐Tee Khaw, Douglas F. Easton, Alison M. Dunning	128
19	Common Polymorphisms in the Prostaglandin Pathway Genes and Their Association with Breast Cancer Susceptibility and Survival 2009 ·Clinical Cancer Research ·Jean Abraham, Patricia Harrington, Kristy Driver, Jonathan P. Tyrer, Douglas F. Easton, Alison M. Dunning, Paul D.P. Pharoah	49
20	Tagging Single-Nucleotide Polymorphisms in Antioxidant Defense Enzymes and Susceptibility to Breast Cancer 2006 ·Cancer Research ·Arancha Cebrián, Paul D.P. Pharoah, Shahana Ahmed, Paula Smith, Craig Luccarini, Robert Luben, Karen Redman, Hannah Munday, Douglas F. Easton, Alison M. Dunning, Bruce A.J. Ponder	68

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact